Clinical trial
Evaluation of Diagnostic and Prognostic Molecular Markers in Adrenal Neoplasm
NCT01348698 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Diagnostic and Prognostic Molecular Markers in Adrenal Neoplasm
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Terminated
- Start date
- May 4, 2011
- Completion date
- January 12, 2018
- Enrollment
- 74 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.